Evidence map›Paper›PMID 33584980›Full record

ReviewWorld journal of stem cells2021

Pancreatic β cell regeneration induced by clinical and preclinical agents.

Kang-Li Wang, Ming Tao, Tian-Jiao Wei, Rui Wei

Open access · greenAbstract readReview
In one paragraph

Review in World journal of stem cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Attenuation of diabetes linked testicular co-morbidity byAvicenna journal of phytomedicine · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kang-Li WangDepartment of Endocrinology and Metabolism, Peking University Third Hospital, Beijing 100191, China.
Ming TaoDepartment of General Surgery, Peking University Third Hospital, Beijing 100191, China.
Tian-Jiao WeiDepartment of Endocrinology and Metabolism, Peking University Third Hospital, Beijing 100191, China.
Rui WeiDepartment of Endocrinology and Metabolism, Peking University Third Hospital, Beijing 100191, China. weirui@bjmu.edu.cn.
Peking University Third Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes, one of the most common chronic diseases in the modern world, has pancreatic β cell deficiency as a major part of its pathophysiological mechanism. Pancreatic regeneration is a potential therapeutic strategy for the recovery of β cell loss. However, endocrine islets have limited regenerative capacity, especially in adult humans. Almost all hypoglycemic drugs can protect β cells by inhibiting β cell apoptosis and dedifferentiation

Indexed as

Cell proliferationEnteroendocrine progenitor cellsPancreatic progenitorsα-to-β cell transdifferentiationβ cell dedifferentiationβ cell regeneration

Identifiers

PMID33584980
PMCPMC7859987
OpenAlexW3123641251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.